Concepedia

Author

Amarnath Sharma

Pfizer (United States)

Also Known As

Amarnath Sharma, Zhenhua Xu

71

Publications

3.5K

Citations

30

H-Index

79

Concepts

All Affiliations

Pfizer (United States)Janssen (United States)University at Buffalo, State University of New YorkSpringhouseRoswell Park Comprehensive Cancer Center
AS

About

Amarnath Sharma is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

29

1.2K

2

Health Sciences

6

6

281

3

Public Health

2

2

24

4

Allergy

2

2

48

5

Social Sciences

1

1

13

Amarnath Sharma

×

48

Publications

3.2K

Citations

28

H-Index

YearCitations

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas, Luis H. Camacho, Gabriel Lopez‐Berestein,

Journal of Clinical Oncology

2005

584

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Paul Haluska, Heather M. Shaw, Gretchen N. Batzel,

Clinical Cancer Research

2007

266

Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes

Amarnath Sharma, Robert M. Straubinger

Pharmaceutical Research

1994

213

Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma

Martha Q. Lacy, Melissa Alsina, Rafaël Fonseca,

Journal of Clinical Oncology

2008

160

Pharmacokinetics and Safety of Duloxetine, a Dual‐Serotonin and Norepinephrine Reuptake Inhibitor

Amarnath Sharma, Mark J. Goldberg, Benito J. Cerimele

The Journal of Clinical Pharmacology

2000

146

Activity of paclitaxel liposome formulations against human ovarian tumor xenografts

Amarnath Sharma, E. Mayhew, Lois E. Bolcsak,

International Journal of Cancer

1997

136

Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena††Supported in part by Grant No. 24211 from the National Institute of General Medical Science, National Institutes of Health.

Amarnath Sharma, William F. Ebling, William J. Jusko

Journal of Pharmaceutical Sciences

1998

124

Characterization of four basic models of indirect pharmacodynamic responses

Amarnath Sharma, William J. Jusko

Journal of Pharmacokinetics and Biopharmaceutics

1996

122

Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy

Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma,

Investigational New Drugs

1999

96

Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia

Amarnath Sharma, Uma Shanker Sharma, Robert M. Straubinger

Cancer Letters

1996

92

Page 1